Ziritaxestat not found effective in patients with idiopathic pulmonary fibrosis: JAMA Jacinthlyn Sylvia15 May 2023 9:00 AM ISTA new study by Toby Maher and team showed that patients with idiopathic pulmonary fibrosis (IPF) getting standard of care medication with pirfenidone...
Weight loss significant among patients with idiopathic pulmonary fibrosis treated with nintedanib Medha Baranwal14 April 2023 8:00 PM ISTJapan: A recent study published in Pulmonary Pharmacology & Therapeutics has shown weight loss to be a critical issue for managing...
Nintedanib effective and safe for elderly patients with idiopathic pulmonary fibrosis Dr.Niharika Harsha B28 March 2023 9:45 AM ISTResearchers have found in a new research that Nintedanib is effective and safe for elderly patients with idiopathic pulmonary fibrosis with clinical...
Serum Rcn3 level helpful for diagnosis of connective tissue disease-associated interstitial lung disease: Study Medha Baranwal28 Feb 2023 8:00 PM ISTChina: Serum reticulocalbin 3 (Rcn3) levels could be a clinically useful biomarker for the screening and evaluating connective tissue...
Lower dose of Pirfenidone as effective as full dose for reducing disease progression in IPF Aditi10 Feb 2023 10:00 AM ISTKorea: A study published in the Korean Journal of Internal Medicine has concluded that the pirfenidone effect for reducing the progression of...
Patent infringement: Roche loses US appeal in Sandoz lung disease drug case Ruchika Sharma24 Dec 2022 11:30 AM ISTSan Francisco-based Genentech's Esbriet is used to treat IPF, a serious chronic lung disease. Roche earned over $1 billion last year from worldwide...
Dynamic contrast enhanced MRI may reveal hemodynamic changes in idiopathic pulmonary fibrosis. Dr.Niharika Harsha B20 Nov 2022 8:00 PM ISTA new study revealed that dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) can identify regional changes in pulmonary hemodynamics in...
Low dosage of corticosteroid may improve prognosis of idiopathic pulmonary fibrosis: BMC Jacinthlyn Sylvia7 Nov 2022 10:30 AM ISTA new study conducted by Keisuke Anan and team showed that in individuals with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), early...
Statins may reduce risk of lung cancer among patients of idiopathic pulmonary fibrosis Dr. Kamal Kant Kohli31 Oct 2022 12:00 PM ISTKOREA: According to research findings presented at the American College of Chest Physicians (CHEST) 2022 Annual Meeting, conducted on October 16–19 in...
Antifibrotics improve quality of life in idiopathic pulmonary fibrosis: Study Dr. Kamal Kant Kohli28 Oct 2022 8:15 PM ISTDENMARK: In terms of enhancing survival, treatment with nintedanib and pirfenidone was preferred to no antifibrotic medication, regardless of the...
Conduct Active Surveillance Study: CDSCO Panel tells Cipla on Idiopathic Pulmonary Fibrosis Drug Pirfenidone tablet Dr. Divya Colin13 Oct 2022 6:00 PM ISTNew Delhi: Denying the pharma major Cipla's request for waiver of an active surveillance study, the Subject Expert Committee (SEC) functional under...
Nalbuphine beneficial for idiopathic pulmonary fibrosis related Chronic Cough in Early Trial Dr. Shravani Dali9 Sept 2022 5:00 AM ISTNalbuphine is beneficial for idiopathic pulmonary fibrosis (IPF) associated Chronic Cough in Early Trial according to a recent study published in ...
